BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11117374)

  • 21. [Disproportionate shortening of left ventricular diastolic duration in patients with dilated cardiomyopathy].
    Plehn G; Vormbrock J; Zühlke C; Christ M; Perings C; Perings S; Trappe HJ; Meissner A
    Med Klin (Munich); 2007 Sep; 102(9):707-13. PubMed ID: 17879008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessments of left ventricular function during exercise in patients with dilated cardiomyopathy: comparison with ischemic cardiomyopathy.
    Konishi T; Koyama T; Aoki T; Yada T; Futagami Y; Sekioka K; Nakano T
    J Cardiol; 1989 Sep; 19(3):797-804. PubMed ID: 2641774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy.
    Clements IP; Miller WL
    Am Heart J; 2001 Feb; 141(2):259. PubMed ID: 11174349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nisoldipine and/or enalapril on left ventricular function and exercise capacity in patients with recent anterior myocardial infarction and mild cardiac dysfunction.
    Romano M; Cardei S; de Arcangelis E; Monteforte I; Capaldo M; Muto P; Marchegiano R; Kilama MO; Condorelli M
    Am Heart J; 1997 Mar; 133(3):268-72. PubMed ID: 9060793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No Evidence of Myocardial Oxygen Deprivation in Nonischemic Heart Failure.
    Dass S; Holloway CJ; Cochlin LE; Rider OJ; Mahmod M; Robson M; Sever E; Clarke K; Watkins H; Ashrafian H; Karamitsos TD; Neubauer S
    Circ Heart Fail; 2015 Nov; 8(6):1088-93. PubMed ID: 26333351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
    Vogler AC; Silber S; Vogel M; Theisen K
    Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of coronary and microvascular flow reserve in patients with nonischemic dilated cardiomyopathy.
    Lima MF; Mathias W; Sbano JC; de la Cruz VY; Abduch MC; Lima MS; Bocchi EA; Hajjar LA; Ramires JA; Kalil Filho R; Tsutsui JM
    J Am Soc Echocardiogr; 2013 Mar; 26(3):278-87. PubMed ID: 23290499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy.
    Tansley P; Yacoub M; Rimoldi O; Birks E; Hardy J; Hipkin M; Bowles C; Kindler H; Dutka D; Camici PG
    J Heart Lung Transplant; 2004 Nov; 23(11):1283-9. PubMed ID: 15539127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy.
    Stolen KQ; Kemppainen J; Kalliokoski KK; Hällsten K; Luotolahti M; Karanko H; Lehikoinen P; Viljanen T; Salo T; Airaksinen KE; Nuutila P; Knuuti J
    J Card Fail; 2004 Apr; 10(2):132-40. PubMed ID: 15101025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction.
    Gerber BL; Melin JA; Bol A; Labar D; Cogneau M; Michel C; Vanoverschelde JL
    J Nucl Med; 1998 Oct; 39(10):1655-62. PubMed ID: 9776263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MIC trial: metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing.
    Genth-Zotz S; Zotz RJ; Sigmund M; Hanrath P; Hartmann D; Böhm M; Waagstein F; Treese N; Meyer J; Darius H
    Eur J Heart Fail; 2000 Jun; 2(2):175-81. PubMed ID: 10856731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
    Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
    Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary microvascular reactivity to sympathetic stimulation in patients with idiopathic dilated cardiomyopathy.
    Drzezga AE; Blasini R; Ziegler SI; Bengel FM; Picker W; Schwaiger M
    J Nucl Med; 2000 May; 41(5):837-44. PubMed ID: 10809200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of cardiopulmonary exercise test in cardiac function evaluation of patients with chronic left heart failure caused by dilated cardiomyopathy].
    Zhang W; Huang J; Xu H; Zhang S; Liu Z; Liao Z; Ma X; Liu Q
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(14):1076-9. PubMed ID: 24851891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study.
    Knaapen P; Götte MJ; Paulus WJ; Zwanenburg JJ; Dijkmans PA; Boellaard R; Marcus JT; Twisk JW; Visser CA; van Rossum AC; Lammertsma AA; Visser FC
    Radiology; 2006 Aug; 240(2):380-8. PubMed ID: 16864667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy.
    van den Heuvel AF; van Veldhuisen DJ; van der Wall EE; Blanksma PK; Siebelink HM; Vaalburg WM; van Gilst WH; Crijns HJ
    J Am Coll Cardiol; 2000 Jan; 35(1):19-28. PubMed ID: 10636254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of diastolic and systolic function on exercise performance in heart failure due to dilated cardiomyopathy or ischemic heart disease.
    Pepi M; Agostoni P; Marenzi G; Dorai E; Guazzi M; Lauri G; Maltagliati A; Guazzi M
    Eur J Heart Fail; 1999 Jun; 1(2):161-7. PubMed ID: 10937926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy.
    Ramahi TM; Longo MD; Cadariu AR; Rohlfs K; Slade M; Carolan S; Vallejo E; Wackers FJ
    Eur Heart J; 2001 May; 22(10):849-56. PubMed ID: 11350094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function.
    Shah NR; Cheezum MK; Veeranna V; Horgan SJ; Taqueti VR; Murthy VL; Foster C; Hainer J; Daniels KM; Rivero J; Shah AM; Stone PH; Morrow DA; Steigner ML; Dorbala S; Blankstein R; Di Carli MF
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.